ESR2 and breast cancer: As presented in Figure 8A and B, breast cancer patients with elevated expression of PTGS2/ESR2/EGFR/JUN/MMP2 genes’ signature displayed significantly poor OS (P =  0.026) and DMFS (P =  0.0066) and consequently unfavorable prognosis.